{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:31:32Z","timestamp":1769099492121,"version":"3.49.0"},"reference-count":33,"publisher":"Georg Thieme Verlag KG","issue":"01","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pneumologie"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Diese \u00dcbersicht enth\u00e4lt Impfempfehlungen f\u00fcr Erwachsene f\u00fcr Pneumologen und ber\u00fccksichtigt basierend auf den neuesten STIKO-Leitlinien Erreger wie Pneumokokken, Influenza, RSV und SARS-CoV-2, aber auch Herpes Zoster und Pertussis. Eine Grafik bietet eine Entscheidungshilfe, indem sie die Impfempfehlungen visuell zusammenfasst, die Beurteilung m\u00f6glicher Koadministrationen erleichtert und eine schnelle, evidenzbasierte Umsetzung im klinischen Alltag unterst\u00fctzt.<\/jats:p>","DOI":"10.1055\/a-2732-6651","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T23:51:44Z","timestamp":1765410704000},"page":"21-26","source":"Crossref","is-referenced-by-count":0,"title":["Empfehlungen f\u00fcr die Impfung Erwachsener f\u00fcr Pneumologen"],"prefix":"10.1055","volume":"80","author":[{"given":"Santiago","family":"Ewig","sequence":"additional","affiliation":[{"name":"Kliniken f\u00fcr Pneumologie und Infektiologie, EVK Herne und Augusta Krankenhaus Bochum, Thoraxzentrum Ruhrgebiet, Bochum, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher Alexander","family":"Hinze","sequence":"additional","affiliation":[{"name":"Respiratory medicine and Infectious disease, Hannover Medical School, Hannover, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Vogelmaier","sequence":"additional","affiliation":[{"name":"Pneumologie, Medizinische Klinik, Marburg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Stierl","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline GmbH & Co. KG, M\u00fcnchen, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Rademacher","sequence":"additional","affiliation":[{"name":"Respiratory medicine and Infectious disease, Hannover Medical School, Hannover, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"ref1","first-page":"114","article-title":"The Increase in Invasive Bacterial Infections With Respiratory Transmission in Germany, 2022\/2023","volume":"121","author":"R Singer","year":"2024","journal-title":"Dtsch Arztebl Int"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s15010-021-01605-w","article-title":"Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade","volume":"49","author":"DCW Braeken","year":"2021","journal-title":"Infection"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"ofu024","DOI":"10.1093\/ofid\/ofu024","article-title":"Rates of pneumococcal disease in adults with chronic medical conditions","volume":"1","author":"KM Shea","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s40265-022-01733-z","article-title":"20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults","volume":"82","author":"M Shirley","year":"2022","journal-title":"Drugs"},{"key":"ref5","first-page":"3","article-title":"Aktualisierung der Empfehlungen der STIKO zur Standardimpfung von Personen \u226560 Jahre sowie zur Indikationsimpfung von Risikogruppen gegen Pneumokokken und die dazugeh\u00f6rige wissenschaftliche Begr\u00fcndung","volume":"39","author":"J Schlaberg","year":"2023","journal-title":"Epid Bull"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae459","article-title":"Relative Effectiveness of the MF59-Adjuvanted Influenza Vaccine Versus High-Dose Influenza Vaccine in Older Adults With Influenza Risk Factors During the 2019\u20132020 US Influenza Season","volume":"11","author":"M Imran","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"ref7","first-page":"3","article-title":"Beschluss und Wissenschaftliche Begr\u00fcndung der St\u00e4ndigen Impfkommission (STIKO)\n          f\u00fcr die Aktualisierung der Influenza-Impfempfehlung f\u00fcr Personen im Alter von \u226560\n          Jahren","volume":"1","author":"K Michaelis","year":"2021","journal-title":"Epid Bull"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e13288","DOI":"10.1111\/irv.13288","article-title":"Relative Effectiveness of the MF59\u00ae-Adjuvanted Influenza Vaccine Versus High-Dose and Non-Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019\u20132020 US Influenza Season","volume":"18","author":"M Imran","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"CA DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S2213-2600(24)00255-8","article-title":"Respiratory syncytial virus infections in adults: a narrative review","volume":"12","author":"JG Wildenbeest","year":"2024","journal-title":"Lancet Respir Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults","volume":"388","author":"EE Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults","volume":"388","author":"A Papi","year":"2023","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults","volume":"389","author":"E Wilson","year":"2023","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMc2311560","article-title":"RENOIR Trial \u2013 RSVpreF Vaccine Efficacy over Two Seasons","volume":"391","author":"EE Walsh","year":"2024","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/cid\/ciae010","article-title":"Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons","volume":"78","author":"MG Ison","year":"2024","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S2213-2600(25)00048-7","article-title":"Efficacy, safety, and immunogenicity of the AS01(E)-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial","volume":"13","author":"MG Ison","year":"2025","journal-title":"Lancet Respir Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s40121-024-00985-4","article-title":"Randomized, Open-Label Phase\u00a03 Study Evaluating Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Coadministered with FLU-QIV-HD in Adults Aged\u2009\u2265\u200965","volume":"13","author":"R Buynak","year":"2024","journal-title":"Infect Dis Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/cid\/ciae365","article-title":"Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial","volume":"79","author":"R Clark","year":"2024","journal-title":"Clin Infect Dis"},{"key":"ref19","first-page":"3","article-title":"Beschluss und Wissenschaftliche Begr\u00fcndung zur Empfehlung der STIKO f\u00fcr eine\n          Standardimpfung gegen Erkrankungen durch Respiratorische Synzytial-Viren (RSV) f\u00fcr\n          Personen \u226575 Jahre sowie zur Indikationsimpfung von Personen im Alter von 60 bis 74 Jahren\n          mit Risikofaktoren","volume":"32","author":"A Falman","year":"2024","journal-title":"Epid Bull"},{"key":"ref20","first-page":"3","article-title":"Beschluss und Wissenschaftliche Begr\u00fcndung zur Ausweitung der STIKO-Empfehlung der Standardimpfung gegen Erkrankungen durch Respiratorische Synzytial-Viren (RSV) f\u00fcr Personen \u226575 Jahre sowie der Indikationsimpfung von Personen im Alter von 60 bis 74 Jahren mit Risikofaktoren um einen mRNA-Impfstoff","volume":"15","author":"A Falman","year":"2025","journal-title":"Epid Bull"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s15010-024-02412-9","article-title":"Comparison of SARS-CoV-2 related in-hospital mortality, ICU admission and mechanical ventilation of 1.4 million patients in Germany and Switzerland, 2019 to 2022","volume":"53","author":"C Kodde","year":"2024","journal-title":"Infection"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/vaccines12070734","article-title":"Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2\/3 Trial","volume":"12","author":"J Gayed","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1093\/infdis\/jiae067","article-title":"Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines","volume":"230","author":"S Chalkias","year":"2024","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1093\/infdis\/jiad508","article-title":"Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial","volume":"230","author":"C Bennett","year":"2024","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"N Bobrovitz","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"ref26","first-page":"3","article-title":"Aktualisierung der COVID-19-Impfempfehlung in den allgemeinen Empfehlungen der STIKO 2024 und die dazugeh\u00f6rige wissenschaftliche Begr\u00fcndung","volume":"2","author":"V Piechotta","year":"2024","journal-title":"Epid Bull"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1503\/cmaj.101137","article-title":"Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a\n          population-based study","volume":"183","author":"YW Yang","year":"2011","journal-title":"CMAJ"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/cid\/ciab121","article-title":"Effectiveness of the Recombinant Zoster Vaccine in Adults Aged 50 and Older in the United States: A Claims-Based Cohort Study","volume":"73","author":"Y Sun","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older","volume":"375","author":"AL Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/cid\/ciz770","article-title":"Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine","volume":"70","author":"MJ Levin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref31","first-page":"541","article-title":"Wissenschaftliche Begr\u00fcndung zur Empfehlung einer Impfung mit dem Herpes zoster-subunit-Totimpfstoff","volume":"50","author":"St\u00e4ndige Impfkommission (STIKO)","year":"2018","journal-title":"Epid Bull"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.chest.2023.12.020","article-title":"Increased Burden of Pertussis Among Adolescents and Adults With Asthma or COPD in the United States, 2007 to 2019","volume":"165","author":"S Naeger","year":"2024","journal-title":"Chest"},{"key":"ref33","first-page":"125","article-title":"\u00dcberpr\u00fcfung der Impfempfehlung f\u00fcr eine einmalige Pertussis(ap)-Impfung im Erwachsenenalter","volume":"15","author":"St\u00e4ndige Impfkommission beim RKI","year":"2019","journal-title":"Epid Bull"}],"container-title":["Pneumologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2732-6651.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T23:50:51Z","timestamp":1769039451000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2732-6651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":33,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2026,1,21]]},"published-print":{"date-parts":[[2026,1]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2732-6651","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0934-8387","1438-8790"],"issn-type":[{"value":"0934-8387","type":"print"},{"value":"1438-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]}}}